Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
ACS Appl Bio Mater ; 7(5): 3050-3060, 2024 05 20.
Article En | MEDLINE | ID: mdl-38598772

Peptides are a promising skincare ingredient, but due to their inherent instability and the barrier function of the skin's surface, they often have limited skin absorption and penetration, which can significantly hinder their skincare benefits. To address this, a novel technique called NanoGlow has been introduced for encapsulating peptide-based cosmetic raw materials into engineered nanosized plant-derived exosomes (pExo) to achieve the goal of a healthier and more radiant skin state. In this approach, pExo served as carriers for cosmetic peptides across the intact skin barrier, enhancing their biological effectiveness in skin beauty. The NanoGlow strategy combines chemical activation and physical proencapsulation, boasting a high success rate and straightforward and stable operation, making it suitable for large-scale production. Comprehensive analysis using in vitro cellular absorption and skin penetration models has demonstrated that the nanosized pExo carriers significantly improve peptide penetration into the skin compared to free peptides. Furthermore, in vivo tissue slice studies have shown that pExo carriers efficiently deliver acetyl hexapeptide-8 to the skin's dermis, surpassing the performance of free peptides. Cosmetic skincare effect analysis has also indicated that pExo-loaded cosmetic peptides deliver superior results. Therefore, the NanoGlow technique harnesses the natural size and properties of pExo to maximize the bioavailability of cosmetic peptides, holding great promise for developing advanced peptide delivery systems in both the cosmetic and medical drug industries.


Biocompatible Materials , Cosmetics , Exosomes , Peptides , Exosomes/chemistry , Exosomes/metabolism , Cosmetics/chemistry , Peptides/chemistry , Peptides/administration & dosage , Biocompatible Materials/chemistry , Humans , Materials Testing , Particle Size , Skin/metabolism , Animals , Drug Delivery Systems , Plants/chemistry , Plants/metabolism , Skin Absorption , Drug Carriers/chemistry
2.
Molecules ; 28(5)2023 Feb 26.
Article En | MEDLINE | ID: mdl-36903418

Leontopodium alpinum is an important source of raw material for food, medicine, and modern cosmetics. The purpose of this study was to develop a new application for protection against blue light damage. To investigate the effects and mechanism of action of Leontopodium alpinum callus culture extract (LACCE) on blue light damage, a blue-light-induced human foreskin fibroblast damage model was established. The contents of collagen (COL-I), matrix metalloproteinase 1 (MMP-1), and opsin 3 (OPN3) were detected using enzyme-linked immunosorbent assays and Western blotting. The calcium influx and reactive oxygen species (ROS) levels were measured via flow cytometry and the results showed that the LACCE (10-15 mg/mL) promoted the production of COL-I, inhibited the secretion of MMP-1, OPN3, ROS and calcium influx, and may play a role in inhibiting the activation of blue light on the OPN3-calcium pathway. Thereafter, high-performance liquid chromatography and ultra-performance liquid chromatography-tandem mass spectrometry were used to quantitatively analyze the contents of nine active ingredients in the LACCE. The results indicated that LACCE has an anti-blue-light-damage effect and provides theoretical support for the development of new raw materials in the natural food, medicine, and skin care industries.


Foreskin , Matrix Metalloproteinase 1 , Humans , Male , Reactive Oxygen Species/metabolism , Matrix Metalloproteinase 1/metabolism , Foreskin/metabolism , Calcium/pharmacology , Plant Extracts/chemistry , Fibroblasts , Rod Opsins/pharmacology
...